Condition
Respiratory Infections, Acute
Total Trials
6
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
33.3%
2 terminated out of 6 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Completed2
Terminated2
Not Yet Recruiting2
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07348380Not ApplicableNot Yet Recruiting
Volatile Organic Compounds Analysis by PTR-TOF-MS for Screening Respiratory Infections Using Exhaled Breath.
NCT06893237Not ApplicableNot Yet RecruitingPrimary
The Effect of Virtual Reality Goggles and Distraction Cards Applied to Children Aged 6-12 Years During Inhaler Therapy on Physiological Parameters and Anxiety
NCT00246480CompletedPrimary
RSV Disease in the Elderly
NCT00133432Phase 3TerminatedPrimary
Zinc and Pneumonia Protocol
NCT00170495TerminatedPrimary
Acute Viral Respiratory Infections in Elderly
NCT00100373Not ApplicableCompletedPrimary
RSV Challenge in Healthy Adults
Showing all 6 trials